220 results on '"Bernier, Jacques"'
Search Results
2. Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses
3. Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells
4. Intrauterine Administration of Activated Peripheral Blood Mononuclear Cells in Intrauterine Insemination: A Prospective Double-Blind Randomized Clinical Trial
5. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway
6. Environmental Exposition to Aromatic Hydrocarbon Receptor Ligands Modulates the CD4+ T Lymphocyte Subpopulations Profile
7. Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes – Past, present and future
8. DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis
9. Sparse proportional re-scanning with hadron beams
10. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
11. Precision medicine for early breast cancer radiotherapy: Opening up new horizons?
12. Development and use of health outcome descriptors: a guideline development case study
13. Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
14. Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics
15. Recent advances in regional treatment of breast carcinoma
16. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus
17. Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: A review
18. Post-mastectomy radiotherapy after neodjuvant chemotherapy in breast cancer patients: A review
19. Silver and fullerene nanoparticles’ effect on interleukin-2-dependent proliferation of CD4 (+) T cells
20. Radiotherapy in DCIS, an underestimated benefit?
21. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells
22. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers: Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)
23. Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94)
24. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology
25. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94)
26. EORTC Radiation Oncology Group: 50 years of continuous accomplishments
27. LPS response and endotoxin tolerance in Flt-3L-induced bone marrow-derived dendritic cells
28. Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer—Reply
29. Chirurgie de reconstruction et radiothérapie du cancer du sein
30. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
31. Translational breast cancer research: Recent advances through the lens of experimental radiotherapy
32. Environmental Workplace Assessment.
33. Ahern, historien de la médecine
34. Patient perceptions of the mandibular three-implant overdenture: a practice-based study
35. Current State-of-the-Art for Concurrent Chemoradiation
36. Burn injury induces the expression of cystine/glutamate transporter (x c−) in mouse T cells
37. Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies.
38. ANDRÉ PARADIS (1941-1997)
39. An Economic Evaluation of Cetuximab Combined with Radiotherapy for Patients with Locally Advanced Head and Neck Cancer in Belgium, France, Italy, Switzerland, and the United Kingdom
40. Incorporation of Molecularly Targeted Agents in the Primary Treatment of Squamous Cell Carcinomas of the Head and Neck
41. EORTC 22972–26991/MRC BR10 trial: Fractionated stereotactic boost following conventional radiotherapy of high grade gliomas: Clinical and quality-assurance results of the stereotactic boost arm
42. Selective effect of burn injury on splenic CD11c+ dendritic cells and CD8α+CD4−CD11c+ dendritic cell subsets
43. Involvement of tyrosine phosphatase CD45 in apoptosis
44. Involvement of CD45 in DNA fragmentation in apoptosis induced by mitochondrial perturbing agents
45. Early Morbidity after Radiotherapy with or without Chemotherapy in Advanced Head and Neck Cancer: Experience from Four Nonrandomized Studies
46. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
47. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts
48. CHEMOTHERAPY: Chemoradiation in head-and-neck cancer—are we any closer?
49. Molecular therapy in head and neck oncology
50. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.